title: TREM-1 amplifies inflammation and is a crucial mediator of septic shock.
abstract: Host innate responses to bacterial infections are primarily mediated by neutrophils and monocytes/macrophages. These cells express pattern recognition receptors (PRRs) that bind conserved molecular structures shared by groups of microorganisms. Stimulation of PRR signalling pathways initiates secretion of proinflammatory mediators, which promote the elimination of infectious agents and the induction of tissue repair. Excessive inflammation owing to bacterial infections can lead to tissue damage and septic shock. Here we show that inflammatory responses to microbial products are amplified by a pathway mediated by triggering receptor expressed on myeloid cells (TREM)-1. TREM-1 is an activating receptor expressed at high levels on neutrophils and monocytes that infiltrate human tissues infected with bacteria. Furthermore, it is upregulated on peritoneal neutrophils of patients with microbial sepsis and mice with experimental lipopolysaccaride (LPS)-induced shock. Notably, blockade of TREM-1 protects mice against LPS-induced shock, as well as microbial sepsis caused by live Escherichia coli or caecal ligation and puncture. These results demonstrate a critical function of TREM-1 in acute inflammatory responses to bacteria and implicate TREM-1 as a potential therapeutic target for septic shock.
authors.affiliation: Basel Institute for Immunology, Grenzacherstrasse 487, CH-4005 Basel, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Bouchon
authors.forename: F
authors.initials: F
authors.lastname: Facchetti
authors.forename: M A
authors.initials: MA
authors.lastname: Weigand
authors.forename: M
authors.initials: M
authors.lastname: Colonna
mesh_terms: D000818:Animals; D001232:Aspergillus fumigatus / Q000276:immunology; D001424:Bacterial Infections / Q000276:immunology; D018416:Bartonella henselae / Q000276:immunology; D003001:Cloning, Molecular; D005260:Female; D006090:Gram-Negative Bacteria / Q000276:immunology; D006094:Gram-Positive Bacteria / Q000276:immunology; D006801:Humans; D007249:Inflammation / Q000378:metabolism*; D018836:Inflammation Mediators / Q000502:physiology*; D008070:Lipopolysaccharides / Q000276:immunology; D008562:Membrane Glycoproteins; D051379:Mice; D008810:Mice, Inbred C57BL; D009000:Monocytes / Q000276:immunology; D009181:Mycoses / Q000276:immunology; D009504:Neutrophils / Q000378:metabolism; D010538:Peritonitis / Q000276:immunology / Q000382:microbiology; D011971:Receptors, Immunologic / Q000235:genetics / Q000502:physiology*; D012772:Shock, Septic / Q000276:immunology*; D013211:Staphylococcus aureus / Q000276:immunology; D000073871:Triggering Receptor Expressed on Myeloid Cells-1; D015854:Up-Regulation
chemical_list: D018836:Inflammation Mediators; D008070:Lipopolysaccharides; D008562:Membrane Glycoproteins; D011971:Receptors, Immunologic; C408842:TREM1 protein, human; D000073871:Triggering Receptor Expressed on Myeloid Cells-1